Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
Immunology Today
|
October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to man
G Parmiani, M Sensi, G Fossati
Acta Diabetologica Latina
|
October 1, 1981
Antibody-dependent and natural killer cytotoxicity in type 1 diabetes
M Sensi, P Pozzilli, A G Cudworth
Journal of Clinical & Laboratory Immunology
|
February 1, 1984
A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates
M Sensi, P Pozzilli, U Di Mario
Biochemical and Biophysical Research Communications
|
January 13, 1978
Changes in nucleotide concentrations in the erythrocytes of man, rabbit and rat during short-term storage
B M Dean, D Perrett, M Sensi
Nephron
|
January 1, 1978
Elevation of rat erythrocyte nucleotide levels following acute renal failure induced by glycerol or mercuric chloride
B M Dean, M Sensi, D Perrett
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1984
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level
M Sensi, C G Orosz, F H Bach
Lancet (London, England)
|
November 13, 1976
Inosine in experimental acute renal failure
L R Baker, W R Cattell, M Sensi
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors
M Sensi, L Grazioli, M Rodolfo, et al.
International Journal of Cancer
|
December 15, 1990
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity
M Sensi, M Bergomi, F Formelli, et al.
Melanoma Research
|
July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?
G Parmiani, A Anichini, G Carbone, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
Immunology Today
|
October 8, 2014
Allostimulation-induced tumor cytotoxic cells: from mouse to man
G Parmiani, M Sensi, G Fossati
Acta Diabetologica Latina
|
October 1, 1981
Antibody-dependent and natural killer cytotoxicity in type 1 diabetes
M Sensi, P Pozzilli, A G Cudworth
Journal of Clinical & Laboratory Immunology
|
February 1, 1984
A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates
M Sensi, P Pozzilli, U Di Mario
Biochemical and Biophysical Research Communications
|
January 13, 1978
Changes in nucleotide concentrations in the erythrocytes of man, rabbit and rat during short-term storage
B M Dean, D Perrett, M Sensi
Nephron
|
January 1, 1978
Elevation of rat erythrocyte nucleotide levels following acute renal failure induced by glycerol or mercuric chloride
B M Dean, M Sensi, D Perrett
Journal of Immunology (Baltimore, Md. : 1950)
|
June 1, 1984
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level
M Sensi, C G Orosz, F H Bach
Lancet (London, England)
|
November 13, 1976
Inosine in experimental acute renal failure
L R Baker, W R Cattell, M Sensi
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors
M Sensi, L Grazioli, M Rodolfo, et al.
International Journal of Cancer
|
December 15, 1990
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity
M Sensi, M Bergomi, F Formelli, et al.
Melanoma Research
|
July 1, 1992
Can oncogene (RAS) activation predict susceptibility of human melanoma to activated lymphocytes and, therefore, the clinical response of such neoplasms to adoptive immunotherapy?
G Parmiani, A Anichini, G Carbone, et al.
Page
of 11